Table 4.

Cerebral hemodynamics evaluation for patients with MMD at 1-year follow-up

Variables	RIC	Sham RIC	P
PSV-baseline	302.5 (259.3–357.8)	342.4 (272.1–353.1)	0.57
PSV-follow-up	257.5 (79.3–314.3)	302.0 (258.7–342.1)	0.22
ΔPSV	45 (− 46.3–263.0)	8.2 (− 13.7–38.9)	0.74
ΔPSV%	19.2 (− 16.5–76.9)	2.4 (− 3.9–13.2)	0.68
EDV-baseline	178.5 (140.5–215.5)	216.0 (161.1–231.7)	0.37
EDV-follow-up	125.5 (56.5–183.0)	187.5 (135.8–210.0)	0.07
ΔEDV	34.5 (− 39.8–169.8)	2.4 (− 2.6–37.7)	0.62
ΔEDV%	22.3 (− 29.3–71.1)	1.3 (− 1.5–21.8)	0.62
MV-baseline	219.8 (171.2–263.0)	252.7 (193.5–275.7)	0.37
MV-follow-up	168.8 (64.1–226.8)	226.7 (181.3–260.3)	0.08
ΔMV	38.0 (− 50.1–189.3)	4.0 (− 6.3–38.1)	0.62
ΔMV%	20.8 (− 28.4–73.6)	1.4 (− 2.6–17.8)	0.62

MMD moyamoya disease, RIC remote ischemic conditioning, PSV peak systolic velocity, ΔPSV change in the mean peak systolic velocity, ΔPSV% percent change in the mean peak systolic velocity, EDV end-diastolic velocity, ΔEDV change in the mean end-diastolic velocity, ΔEDV% percent change in the mean end-diastolic velocity, MV mean velocity, ΔMV change in the mean velocity, ΔMV% percent change in the mean velocity